表紙
市場調查報告書

血型判斷試劑的全球市場:2020年∼2024年

Blood Grouping Reagents Market by End-users and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 919316
出版日期 內容資訊 英文 141 Pages
訂單完成後即時交付
價格
血型判斷試劑的全球市場:2020年∼2024年 Blood Grouping Reagents Market by End-users and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月14日內容資訊: 英文 141 Pages
簡介

全球血型判斷試劑市場上,慢性疾病的盛行率增加,捐血的增加,輸血和血型判斷需求高漲等成為成長促進因素,在預測期間內預計將以10%以上的年複合成長率擴大。可是,輸血相關的風險,熟練的醫護人員不足,及輸血的嚴格法規流程等要素,可能妨礙在預測期內血型判斷試劑產業的成長。

本報告提供全球血型判斷試劑市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2019年∼2024年)
  • 醫院、血液銀行
  • 臨床檢驗室
  • 學術研究機關
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 社群媒體行銷的出現
  • 技術的進步
  • 醫療設施的增加

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Bio-Rad Laboratories Inc.
  • DIAGAST
  • Grifols SA
  • Immucor Inc.
  • Merck KGaA
  • Novacyt SA
  • Ortho-Clinical Diagnostics Inc.
  • Quotient Ltd.
  • Rapid Labs Ltd.
  • Ybio Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40141

About this market

Technavio's blood-grouping reagents market analysis considers sales from hospitals and blood banks; clinical laboratories; and academic and research institute end-users. Our study also finds the sales of blood-grouping reagents in Asia, Europe, North America, and ROW. In 2019, the hospitals and blood banks segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing demand for blood transfusion and the rise in the number of hospitals and clinics will play a significant role in the hospitals and blood banks segment to maintain its market position. Also, our global blood-grouping reagents market report looks at factors such as the increasing prevalence of chronic disorders, the rise in blood donations, and growing demand for blood transfusions and blood group typing. However, the risk associated with blood transfusion, lack of skilled healthcare professionals, and stringent regulatory process for blood transfusion may hamper the growth of the blood-grouping reagents industry over the forecast period.

Overview

Growing demand for blood transfusions and blood group typing

The demand for blood transfusions and blood grouping is growing rapidly, owing to the increase in demand for blood. The increase in demand for blood transfusions can be attributed to several types of emergency cases, including road accidents leading to loss of blood and death. Patients suffering from conditions such as hemolytic anemia, sickle cell anemia, hemophilia, thalassemia, kidney, and liver diseases also require blood transfusion often. This is driving the demand for blood grouping reagents as they are used by blood banks and hospitals for safe transfusion of blood and elimination of risks associated with infections. Thus, the growing demand for blood transfusions and blood group typing will lead to the expansion of the global blood-grouping reagents market at a CAGR of over 10% during the forecast period.

Advancement in technology

Advances in technology help in increasing the adherence of people to diagnosis, which aids in obtaining effective and quick results. Also, the advent of technologies such as molecular typing as a substitute to the traditional blood grouping method is trending. The molecular blood grouping method includes the detection of polymorphisms and mutations that control the expression of blood group antigens. Moreover, automated blood group typing products improve the quality of testing by decreasing human errors in sample identification. Also, the emergence of column agglutination technique (CAT), solid-phase red cell adherence assay (SPRCA), erythrocyte-magnetized technique (EMT), and automated microplate systems will help to improve the quality and accuracy of testing and results. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global blood-grouping reagents market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of a few major players, the global blood-grouping reagents market is concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading blood-grouping reagents manufacturers, that include Bio-Rad Laboratories Inc., DIAGAST, Grifols SA, Immucor Inc., Merck KGaA, Novacyt SA, Ortho-Clinical Diagnostics Inc., Quotient Ltd., Rapid Labs Ltd., and Ybio Inc.

Also, the blood-grouping reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals and blood banks - Market size and forecast 2019-2024
  • Clinical laboratories - Market size and forecast 2019-2024
  • Academic and research institutes - Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges s

PART 11: MARKET TRENDS

  • Emergence of social media marketing
  • Advancement in technology
  • Increasing penetration of healthcare facilities

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bio-Rad Laboratories Inc.
  • DIAGAST
  • Grifols SA
  • Immucor Inc.
  • Merck KGaA
  • Novacyt SA
  • Ortho-Clinical Diagnostics Inc.
  • Quotient Ltd.
  • Rapid Labs Ltd.
  • Ybio Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Vendors: Key offerings
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: End-user - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Hospitals and blood banks - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Hospitals and blood banks - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Clinical laboratories - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Clinical laboratories - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Academic and research institutes - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Academic and research institutes - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2019-2024 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Top 3 countries in North America
  • Exhibit 33: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 34: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 35: Top 3 countries in Europe
  • Exhibit 36: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 37: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Top 3 countries in Asia
  • Exhibit 39: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 40: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 41: Top 3 countries in ROW
  • Exhibit 42: Key leading countries
  • Exhibit 43: Market opportunity
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Vendor landscape
  • Exhibit 46: Landscape disruption
  • Exhibit 47: Vendors covered
  • Exhibit 48: Vendor classification
  • Exhibit 49: Market positioning of vendors
  • Exhibit 50: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 51: Bio-Rad Laboratories Inc. - Product segments
  • Exhibit 52: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 53: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 54: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 55: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 56: DIAGAST - Vendor overview
  • Exhibit 57: DIAGAST - Business segments
  • Exhibit 58: DIAGAST - Key offerings
  • Exhibit 59: Grifols SA - Vendor overview
  • Exhibit 60: Grifols SA - Product segments
  • Exhibit 61: Grifols SA - Organizational developments
  • Exhibit 62: Grifols SA - Geographic focus
  • Exhibit 63: Grifols SA - Segment focus
  • Exhibit 64: Grifols SA - Key offerings
  • Exhibit 65: Immucor Inc. - Vendor overview
  • Exhibit 66: Immucor Inc. - Business segments
  • Exhibit 67: Immucor Inc. - Organizational developments
  • Exhibit 68: Immucor Inc. - Key offerings
  • Exhibit 69: Merck KGaA - Vendor overview
  • Exhibit 70: Merck KGaA - Business segments
  • Exhibit 71: Merck KGaA - Organizational developments
  • Exhibit 72: Merck KGaA - Geographic focus
  • Exhibit 73: Merck KGaA - Segment focus
  • Exhibit 74: Merck KGaA - Key offerings
  • Exhibit 75: Novacyt SA - Vendor overview
  • Exhibit 76: Novacyt SA - Business segments
  • Exhibit 77: Novacyt SA - Organizational developments
  • Exhibit 78: Novacyt SA - Geographic focus
  • Exhibit 79: Novacyt SA - Segment focus
  • Exhibit 80: Novacyt SA - Key offerings
  • Exhibit 81: Ortho-Clinical Diagnostics Inc. - Vendor overview
  • Exhibit 82: Ortho-Clinical Diagnostics Inc. - Business segments
  • Exhibit 83: Ortho-Clinical Diagnostics Inc. - Key offerings
  • Exhibit 84: Quotient Ltd. - Vendor overview
  • Exhibit 85: Quotient Ltd. - Business segments
  • Exhibit 86: Quotient Ltd. - Geographic focus
  • Exhibit 87: Quotient Ltd. - Key offerings
  • Exhibit 88: Rapid Labs Ltd. - Vendor overview
  • Exhibit 89: Rapid Labs Ltd. - Product segments
  • Exhibit 90: Rapid Labs Ltd. - Key offerings
  • Exhibit 91: Ybio Inc. - Vendor overview
  • Exhibit 92: Ybio Inc. - Product segments
  • Exhibit 93: Ybio Inc. - Key offerings
  • Exhibit 94: Validation techniques employed for market sizing
  • Exhibit 95: Definition of market positioning of vendors